Search results
Lilia Sierra-Galan
Job title: Head of Cardiology
Author
Author(s):
Yan Topilsky
,
Dana Yaron
,
Meytal Bork
Added:
2 years ago
Author(s):
Mohammad Sahebjalal
,
Nick Curzen
Added:
3 years ago
Antiplatelet therapy (APT) represents a major cornerstone in the secondary prevention of coronary artery disease, along with modifying patients’ risk factors. Furthermore, it has been clear, since early unsuccessful regimens, including warfarin and dypiridamole with aspirin, that it is APT that stops coronary stents from clotting off and causing stent thrombosis.1,2 Specifically, the requirement…
View more
Author(s):
Clemens von Birgelen
Added:
4 years ago
Prof Clemens von Birgelen (University of Twente, Overijssel, Twente, NL) discusses 3-years BIO-RESORT - results of the 3-arm randomised study in all-comers, treated with contemporary biodegradable or durable polymer-coated drug-eluting stents.
Filmed on site at CRT 2019 by Radcliffe Cardiology.
Questions:
1. What is BIO-RESORT and why was it conducted?
2. Could you summarise the study design…
View more
Author(s):
Mark H Anderson
Added:
6 years ago
CRT 2019: SAVAL Trial
Author(s):
Jihad Mustapha
Added:
4 years ago
Video
Carina Blomström-Lundqvist
Job title: Professor of Cardiology
Author
Author(s):
Paolo Masiello
,
Generoso Mastrogiovanni
,
Raffaella Cantatore
,
et al
Added:
4 years ago
Author(s):
Justin E Davies
,
David Kandzari
Added:
5 years ago
Dr Justin Davies (London, UK) and Dr David Kandzari (Atlanta, US) discuss the SPYRAL HTN-ON MED study and how it will affect treatment of hypertension.
Filmed by Radcliffe Cardiology on-site at EuroPCR 2018 in Paris, FR.
Funding to produce this video was provided by an unrestricted grant from:
View more
ESC 2018: FUTURE Trial
Author(s):
Gilles Rioufol
Added:
5 years ago
Video